These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12161113)

  • 21. Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.
    Ogiyama T; Inoue M; Honda S; Yamada H; Watanabe T; Gotoh T; Kiso T; Koakutsu A; Kakimoto S; Shishikura J
    Bioorg Med Chem; 2014 Dec; 22(24):6899-907. PubMed ID: 25456079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke.
    Yamamoto T; Takahara A
    Curr Top Med Chem; 2009; 9(4):377-95. PubMed ID: 19442208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity.
    Beebe X; Darczak D; Henry RF; Vortherms T; Janis R; Namovic M; Donnelly-Roberts D; Kage KL; Surowy C; Milicic I; Niforatos W; Swensen A; Marsh KC; Wetter JM; Franklin P; Baker S; Zhong C; Simler G; Gomez E; Boyce-Rustay JM; Zhu CZ; Stewart AO; Jarvis MF; Scott VE
    Bioorg Med Chem; 2012 Jul; 20(13):4128-39. PubMed ID: 22626552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.
    Hu LY; Ryder TR; Rafferty MF; Siebers KM; Malone T; Chatterjee A; Feng MR; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Drug Des Discov; 2000; 17(1):85-93. PubMed ID: 10928451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
    Son WS; Jeong KS; Lim SM; Pae AN
    Bioorg Med Chem Lett; 2019 May; 29(10):1168-1172. PubMed ID: 30928197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
    Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
    Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.
    Kang B; Oh JA; Lee JY; Rhim H; Yune TY; Park Choo HY
    Bioorg Med Chem; 2015 Sep; 23(18):6166-72. PubMed ID: 26296911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.
    Ogihara T; Kano T; Kakinuma C
    Arzneimittelforschung; 2009; 59(6):283-8. PubMed ID: 19634509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of N-Type Calcium Channels via GABA
    Cai F; Xu N; Liu Z; Ding R; Yu S; Dong M; Wang S; Shen J; Tae HS; Adams DJ; Zhang X; Dai Q
    J Med Chem; 2018 Nov; 61(22):10198-10205. PubMed ID: 30358401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels.
    Swensen AM; Herrington J; Bugianesi RM; Dai G; Haedo RJ; Ratliff KS; Smith MM; Warren VA; Arneric SP; Eduljee C; Parker D; Snutch TP; Hoyt SB; London C; Duffy JL; Kaczorowski GJ; McManus OB
    Mol Pharmacol; 2012 Mar; 81(3):488-97. PubMed ID: 22188924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic properties of S100A9 C-terminal domain: a mechanism dependent on calcium channel inhibition.
    Dale CS; Altier C; Cenac N; Giorgi R; Juliano MA; Juliano L; Zamponi GW; Vergnolle N
    Fundam Clin Pharmacol; 2009 Aug; 23(4):427-38. PubMed ID: 19515068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
    Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2014 May; 24(9):2053-6. PubMed ID: 24726802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
    Melena J; Osborne NN
    Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels.
    Sairaman A; Cardoso FC; Bispat A; Lewis RJ; Duggan PJ; Tuck KL
    Bioorg Med Chem; 2018 Jul; 26(11):3046-3059. PubMed ID: 29622412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
    Callaghan B; Adams DJ
    Channels (Austin); 2010; 4(1):51-4. PubMed ID: 20368690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
    Rhim H; Lee YS; Park SJ; Chung BY; Lee JY
    Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.